Tumor attenuation by 2(6-hydroxynaphthyl)-β-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products

Glycobiology

Volumn 14, Issue 5, 2004, Pages 387-397

  Mani, Katrin ^a   Belting, Mattias ^a   Ellervik, Ulf ^a   Falk, Niklas ^a   Svensson, Gabriel ^a   Sandgren, Staffan ^a   Cheng, Fang ^a   Fransson, Lars Áke ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Heparan sulfate; Nitric oxide; Tumor growth; Xyloside

Indexed keywords

2 (6 HYDROXYNAPHTHYL) BETA DEXTRO XYLOPYRANOSIDE; ANTINEOPLASTIC AGENT; HEPARAN SULFATE; MANNOSE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATTENUATION; CANCER INHIBITION; CARBOHYDRATE SYNTHESIS; CELL NUCLEUS; CELL TRANSFORMATION; CONTROLLED STUDY; DEGRADATION; DRUG DESIGN; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL DIVISION; CELL NUCLEUS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; GLYCOSIDES; HEPARITIN SULFATE; HUMANS; MICE; MICE, SCID; NITRIC OXIDE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 2942620144     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwh035     Document Type: Article

References (22)

1. Belting, M., Persson, S., and Fransson, L.-Å. (1999) Proteoglycan involvement in polyamine uptake. Biochem. J, 338, 317-323.
2. Belting, M., Borsig, L., Fuster, M.M., Brown, J.R., Persson, L., Fransson, L.-Å., and Esko, J.D. (2002) Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc. Natl Acad Sci. USA, 99, 371-376.
3. Belting, M., Mani, K., Jönsson, M., Cheng, F., Sandgren, S., Jonsson, S., Ding, K., Delcros, J.-G. and Fransson, L.-Å. (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells. A pivotal role for nitrosothiol-derived nitric oxide. J. Biol. Chem., 278, 47181-47189
4. Buess, C.M., Guidici, T., Kharasch, N., King, W., Lawson, D.D., and Saha, N.N. (1965) The synthesis of thyromimetic substances and potential inhibitors of thyroxine. J. Med. Chem., 8, 469-474.
5. Cheng, F., Mani, K., van den Born, J., Ding, K., Belting, M., and Fransson, L.-Å. (2002) Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated Gpc-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem., 277, 44431-44439.
6. Ding, K., Jönsson, M., Mani, K., Sandgren, S., Belting, M., and Fransson, L.-Å. (2001a) N-unsubstituted glucosamine in heparan sulfate of recycling Gpc-1 from suramin-treated and nitrite-deprived endothelial cells. Mapping of nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein. J. Biol. Chem., 276, 3885-3894.
7. Ding, K., Sandgren, S., Mani, K., Belting, M., and Fransson, L. -Å. (2001b) Modulations of Gpc-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites. J. Biol Chem., 276, 46779-46791.
8. Ding, K., Mani, K., Cheng, F., Belting, M., and Fransson, L.-Å. (2002) Copper-dependent autocleavage of Gpc-1 heparan sulfate by nitric oxide derived from intrinsic nitrosothiols. J. Biol. Chem., 277, 33353-33360.
9. Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., and Maeda, H. (1996) Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer, 77, 1598-1604.
10. Esko, J.D., Rostand, K.S., and Weinke, J.L. (1988) Tumor formation dependent on proteoglycan biosynthesis. Science, 241, 1092-1096.
11. Fransson, L.-Å. (2003) Glypicans. Int. J. Biochem. Cell Biol., 35, 125-129.
12. Fransson, L.-Å., Karlsson, P., and Schmidtchen, A. (1992) Effects of cycloheximide, brefeldin A, suramin, heparin and primaquine on proteoglycan and glycosaminoglycan biosynthesis in human embryonic skin fibroblasts. Biochim. Biophys. Acta, 1137, 287-297.
13. Fransson, L.-Å., Belting, M., Jönsson, M., Mani, K., Moses, J., and Oldberg, Å. (2000) Biosynthesis of decorin and glypican. Matrix Biol, 19, 367-376.
14. Liu, D., Shriver, Z., Venkataraman, G., El Shabrawi, Y., and Sasisekharan, R. (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl Acad. Sci. USA, 99, 568-573.
15. Mani, K., Havsmark, B., Persson, S., Kaneda, Y., Yamamoto, H., Sakurai, K., Ashikari, S., Habuchi, H., Suzuki, S., Kimata, K., and others. (1998) Heparan/chondroitin/dermatan sulfate primer 2-(6-hydroxynaphthyl)-O-beta-D-xylopyranoside preferentially inhibits growth of transformed cells. Cancer Res., 58, 1099-1104.
16. Mani, K., Jönsson, M., Edgren, G., Belting, M., and Fransson, L.-Å. (2000) A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of Gpc-1 in vascular endothelial cells. Glycobiology, 10, 577-586.
17. Mani, K., Cheng, F., Havsmark, B., Jönsson, M., Belting, M., and Fransson, L.-A. (2003) Prion or amyloid-b-derived Cu(II)- or free Zn(II)-ions support S-nitroso-dependent autocleavage of Gpc-1 heparan sulfate. J. Biol. Chem., 278, 38956-38965.
18. Mori, M., Ito, Y., and Ogawa, T. (1990) Total synthesis of the mollu-series glycosyl ceramides alpha- D-Manp-(1-3)-beta-D-Manp-(1-4)-beta-D-Glcp-(1-1)-Cer and alpha-D-Manp-(1-3)-[beta-D-Xylp-(1-2)]-beta-D-Manp-(1-4 -beta-D-Glcp-(1-1) Cer. Carbohydr. Res., 195,199-224.
19. Moses, J., Oldberg, Å., and Fransson, L.-Å. (1999) Initiation of galactosaminoglycan biosynthesis. Separate galactosylation and dephosphorylation pathways for phosphoxylosylated decorin protein and exogenous xyloside. Eur. J. Biochem., 260, 879-884.
20. Shively, J.E. and Conrad, H.E. (1976) Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry, 15, 3932-3942.
21. Thomas, T. and Thomas, T.J. (2001) Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci, 58, 244-258.
22. Thomsen, L.L. and Miles, D.W. (1998) Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev., 17, 107-118.